(Q40367509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Karl Andersson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Mikael Persson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Lars Gedda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mattias Sandström

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jörgen Carlsson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

29 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1457-1462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16193312%20AND%20SRC:MED&resulttype=core&format=json

Biomarker conservation in primary and metastatic epithelial ovarian cancer

7 January 2020

cites work

1 reference

12 December 2020

Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin

1 reference

12 December 2020

Future directions in radioimmunotherapy for B-cell lymphoma

1 reference

12 December 2020

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

12 December 2020

Tumour therapy with radionuclides: assessment of progress and problems.

1 reference

12 December 2020

Role of HER2/neu in tumor progression and therapy

1 reference

12 December 2020

Advancing role of radiolabeled antibodies in the therapy of cancer

1 reference

12 December 2020

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer

1 reference

12 December 2020

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.

1 reference

12 December 2020

Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.

1 reference

12 December 2020

Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.

1 reference

12 December 2020

Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells

1 reference

12 December 2020

A new therapeutic antibody masks ErbB2 to its partners

1 reference

12 December 2020

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

12 December 2020

A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice

1 reference

12 December 2020